Carl Zeiss Meditec/AFX

€97.98

0.62%
-
1D1W1MYTD1YMAX

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.

Ticker

AFX

Sector

Healthcare

Trading on

XETRA

Industry

Medical Equipment & Supplies

CEO

Markus Weber

Employees

4,823

Headquarters

Jena, Germany

AFX Metrics

BasicAdvanced
€8.73B
Market cap
31.51
P/E ratio
€3.10
EPS
0.75
Beta
€1.10
Dividend rate
1.13%
Dividend yield
€8.73B
0.74529
€126.00
€72.60
131.44K
€1.10
35.55%
31.511
4.171
0.75%
1.13%
1.13%
6.68%
-9.47%
16.09%
33.38%
30.06%

What the Analysts think about AFX

Analyst Ratings

Majority rating from 19 analysts.
Hold

Price Targets

Average projection from 17 analysts.
15.51% upside
High €150.00
Low €94.00
€97.98
Current price
€113.18
Average price target

AFX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
7.85% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
€475M
-18.06%
Net income
€37.3M
-56.17%
Profit margin
7.85%
-46.53%

AFX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 28.83%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
€0.69
€1.03
€0.96
€0.42
-
Expected
€0.79
€0.81
€0.73
€0.33
€0.48
Surprise
-12.1%
27.58%
32.11%
28.83%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Deutsche Börse. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Carl Zeiss Meditec stock?

Carl Zeiss Meditec (AFX) has a market cap of €8.74B as of April 21, 2024.

What is the P/E ratio for Carl Zeiss Meditec stock?

The price to earnings (P/E) ratio for Carl Zeiss Meditec (AFX) stock is 31.53 as of April 21, 2024.

Does Carl Zeiss Meditec stock pay dividends?

Yes, the Carl Zeiss Meditec (AFX) stock pays dividends to shareholders. As of April 21, 2024, the dividend rate is €1.1 and the yield is 1.13%. Carl Zeiss Meditec has a payout ratio of 35.55% on a trailing twelve-month basis.

When is the next Carl Zeiss Meditec dividend payment date?

The next Carl Zeiss Meditec (AFX) dividend payment date is unconfirmed.

What is the beta indicator for Carl Zeiss Meditec?

Carl Zeiss Meditec (AFX) has a beta rating of 0.74. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Carl Zeiss Meditec stock price target?

The target price for Carl Zeiss Meditec (AFX) stock is €113.18, which is 15.51% above the current price of €97.98. This is an average based on projections from 17 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Carl Zeiss Meditec stock

Buy or sell Carl Zeiss Meditec stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing